Jelena Gankina has extensive experience in the pharmaceutical industry. Having graduated as a pharmacist in Moscow, she started her professional career as a scientist in R&D (Scientific Research Institute of Pharmacology, Moscow) and got her Ph.D. in molecular pharmacology. She has presented her scientific results during professional events and in scientific press in Russia and abroad. Since 1994, Jelena has been working in the regulatory field, where she has gathered experience in generic (LEK Pharmaceuticals, PLIVA Hrvatska d.o.o., Polpharma), innovative (Bristol-Myers Squibb) and Russian domestic companies (Akrikhin) in Russia, CIS and the EU in different areas: registration (APIs, medicinal products, medical devices, para-pharmaceuticals), quality, pharmacovigilance and clinical operations.